Trial Profile
A Single-Center, Double Blind, Randomized Crossover Study Evaluating Injection Site Toleration of VIAject 7, VIAject 25 and Insulin Lispro in Subjects with Type 1 or Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Jul 2012
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin lispro
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- 25 Apr 2012 New trial record